Has ‘scaremongering’ about the Oxford jab undermined EU’s vaccination campaign?
People in Germany and France are refusing to be inoculated with the UK-developed vaccine
Contradictory claims about the effectiveness of the Oxford-AstraZeneca vaccine are hindering the rollout of Covid-19 jabs in Germany and several other European nations, latest uptake figures suggest.
The Times reports that Germans are “failing to keep appointments” to have the Oxford jab, a trend that is “threatening to derail what is already a flagging national inoculation plan”.
The country has so far administered just 150,000 of its total stock of 1.5 million doses of the vaccine, following reports in the German media questioning the efficacy of the UK-developed jab.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Some European leaders have also made negative comments about the Oxford vaccine, with the German government deciding not to use it to inoculate patients aged over 65 even though the European Medicines Agency has approved the jab to be given to all adults.
French President Emmanuel Macron has cast doubt on the vaccine too, wrongly claiming at the end of January that “everything suggests that it is almost ineffective for those over 65, and some say over 60”.
Amid the widespread “scaremongering”, people in France are joining their German counterparts in “skipping their appointments after finding out they would receive the Oxford vaccine”, says The Sun.
And the scepticism is not contained to these two countries.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Sweden’s public health agency is also recommended against vaccinating people over 65 with the UK-developed jab, while in Poland the vaccine will only be used for people aged 18-60. Italy has proven even more cautious, recommending the use of the vaccine only to people younger than 55.
Meanwhile, the gaps are widening between nations in the global race to vaccinate populations against the coronavirus. Latest tracking from Oxford University shows that while 27.03 Covid vaccine doses had been administered for every 100 people in the UK as of 21 February, an average of just 6.09 doses per 100 had been administered across the EU.
Create an account with the same email registered to your subscription to unlock access.
Chas Newkey-Burden has been part of The Week Digital team for more than a decade and a journalist for 25 years, starting out on the irreverent football weekly 90 Minutes, before moving to lifestyle magazines Loaded and Attitude. He was a columnist for The Big Issue and landed a world exclusive with David Beckham that became the weekly magazine’s bestselling issue. He now writes regularly for The Guardian, The Telegraph, The Independent, Metro, FourFourTwo and the i new site. He is also the author of a number of non-fiction books.
-
Why are people and elephants fighting in Sri Lanka?
Under The Radar Farmers encroaching into elephant habitats has led to deaths on both sides
By Chas Newkey-Burden, The Week UK Published
-
Indie film's 'very brief' use of AI sparks backlash and calls for boycotts
Talking Points Did the creators of a new horror movie make a deal with the artificial intelligence devil?
By Rafi Schwartz, The Week US Published
-
Could Taylor Swift swing the election?
Today's Big Question The pop star has outsized influence — and that extends beyond the music industry
By Anya Jaremko-Greenwold Published
-
Olaf Scholz vs. Emmanuel Macron: an ancient animosity
Under the radar The German chancellor and French president's relationship has been productive, but Ukraine war has put it under strain
By The Week UK Published
-
Will Aukus pact survive a second Trump presidency?
Today's Big Question US, UK and Australia seek to expand 'game-changer' defence partnership ahead of Republican's possible return to White House
By Sorcha Bradley, The Week UK Published
-
NATO allies say no to Macron's idea of troops in Ukraine
Speed Read The French president faced pushback after suggesting soldiers be deployed to Ukraine
By Peter Weber, The Week US Published
-
It's the economy, Sunak: has 'Rishession' halted Tory fightback?
Today's Big Question PM's pledge to deliver economic growth is 'in tatters' as stagnation and falling living standards threaten Tory election wipeout
By Harriet Marsden, The Week UK Published
-
Why your local council may be going bust
The Explainer Across England, local councils are suffering from grave financial problems
By The Week UK Published
-
Rishi Sunak and the right-wing press: heading for divorce?
Talking Point The Telegraph launches 'assault' on PM just as many Tory MPs are contemplating losing their seats
By Keumars Afifi-Sabet, The Week UK Published
-
AfD and the trouble with banning political parties
Talking point As support for the far-right party surges, politicians are debating whether it poses a threat to German democracy
By Arion McNicoll, The Week UK Last updated
-
How would a second Trump presidency affect Britain?
Today's Big Question Re-election of Republican frontrunner could threaten UK security, warns former head of secret service
By Harriet Marsden, The Week UK Published